Lyra Health
Headquarters
Burlingame, CAFounded
2015CEO / Founder
David EbersmanEmployees
1001-5000Funding
Series D+ — $910MProducts
1 product listedAvg. AI Score
7.9/10Website
lyrahealth.com/
Profile updated
About Lyra Health
Lyra Health is a mental health benefits company founded in 2015 by David Ebersman, former CFO of Facebook and Genentech. Headquartered in Burlingame, California, the company operates a platform that employers purchase to provide mental health care access to their workforce, including therapy, coaching, and medication management.
Lyra's platform matches employees with vetted mental health providers using a proprietary matching algorithm and offers care delivery through video, in-person, and text-based formats. The company serves large enterprise clients including Morgan Stanley, Starbucks, and Uber, and reports covering tens of millions of employees globally. Its provider network includes thousands of therapists and coaches across multiple countries.
Lyra has raised approximately $910 million in total funding across multiple rounds, including a $235 million Series F in January 2022 that valued the company at $5.58 billion. The company has expanded internationally into markets including the UK, Australia, and Canada. As of recent reports, Lyra employs over 1,000 people.
Specialties
Financials
Dated, source-cited figures. Estimates are marked.
Products by Lyra Health
All products by Lyra Health reviewed by our AI panel of experts.
How Our Review Panel Scores Lyra Health
Six independent reviewer personalities assessed Lyra Health's product on their own terms. They disagreed by 1.2 points — The Skeptic was the hardest to convince, The Domain Strategist the most positive.
Averaged across 1 reviewed product in our catalog. Scores are out of 10.
Competitive Landscape
Who Lyra Health competes with, and how they differ.
Uses a validated clinical assessment and an outcomes-trained matching algorithm to route employees to a level of care rather than a curated therapist directory; like Lyra it sells only to employers, not individuals, and both are priced for large enterprises.
Casts a wider net than Lyra's therapy-only, evidence-based-treatment model: it triages employees across a self-reported wellbeing spectrum and leans more on lower-cost, non-licensed coaches and self-guided content alongside therapists.
Combines Ginger's on-demand coaching, therapy and psychiatry with Headspace's consumer meditation and mindfulness app, reaching 3,700+ employers by 2023 — a broader mainstream-wellness brand than Lyra's clinically-gated, evidence-based-treatment-only network.
Sells therapy directly to consumers as well as through employer contracts available to businesses as small as 5 employees, competing on on-demand text/audio/video access and lower price points, while Lyra sells only to employers and targets large enterprises.
Company Timeline
Key milestones in Lyra Health's history, with sources.
- Milestone
Jennifer Schulz becomes CEO, succeeding David Ebersman
Jennifer Schulz, former CEO of Experian North America, became Lyra Health CEO effective January 13, 2025, succeeding co-founder David Ebersman, who moved into the role of Board Chairman.
itdigest.com - Milestone
Lays off 2% of workforce (77 employees)
Lyra Health laid off 77 employees, about 2% of its workforce, in a restructuring co-founder and then-CEO David Ebersman said was needed to set the company up for success in 2025; the cuts did not affect clinicians.
fiercehealthcare.com - Funding
Series G — $235M led by Dragoneer
Lyra Health completed a $235 million financing led by Dragoneer Investment Group, joined by new investor Salesforce Ventures and existing investor Coatue.
prnewswire.com - Acquisition
Acquired ICAS World
Lyra Health acquired ICAS World, a global employee assistance program provider operating in more than 155 countries, to expand its international mental health care services.
prnewswire.com - Funding
Series F — $200M led by Coatue at $4.6B valuation
Lyra Health completed a $200 million Series F led by Coatue with new investor Sands Capital, taking total funding to $680 million and valuation to $4.6 billion.
medcitynews.com - Funding
Series E — $187M led by Addition at $2.3B valuation
Less than six months after reaching unicorn status, Lyra raised a $187 million Series E led by Addition, joined by new investors Durable Capital Partners, Fidelity and Baillie Gifford, valuing the company at $2.3 billion.
news.crunchbase.com - Funding
Series D — $110M led by Addition, unicorn status at $1.1B
Lyra Health became a unicorn following a $110 million Series D round led by Addition, joined by Adams Street Partners and existing investors including Howard Schultz and Greylock Partners.
news.crunchbase.com - Founded
David Ebersman launches Lyra Health
Former Facebook and Genentech CFO David Ebersman launched Lyra Health, a workforce mental health startup, backed initially by seed funding from Venrock.
biospace.com
Explore AI Software Reviews
Browse multi-perspective AI panel reviews across hundreds of AI tools, agents, and platforms. Find the right software with insights from CTO, Developer, Marketer, Finance, and User perspectives.